House Appropriations Committee Embraces Clinical Trial Issues In FY 2022 US FDA Budget Bill
Report language includes several mentions of improving trial diversity and recruitment, while bill offers a 5% increase in funding.
You may also be interested in...
Many companies have been signaling their commitment to diversity and inclusion in trials, but the new draft guidance spells out how they should address it and what the FDA wants to see.
Omnibus package also gives FDA expanded authority over nicotine products and creates President Biden’s Advanced Research Projects Agency for Health.
The bill also would give the FDA expanded authority over nicotine products and create President Biden’s Advanced Research Projects Agency for Health.